Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKAZ.L Regulatory News (KAZ)

  • There is currently no data for KAZ

Form 8.3 - KAZ Minerals plc

31 Mar 2021 15:20

RNS Number : 1406U
BlackRock Group
31 March 2021
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

KAZ Minerals plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

30 March 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

20p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

11,728,468

2.48%

0

0.00%

(2) Cash-settled derivatives:

 

0

0.00%

356,404

0.07%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

 

TOTAL:

11,728,468

2.48%

356,404

0.07%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

20p ordinary

Purchase

768

GBP 8.6640

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

20p ordinary

CFD

Increasing short

4,604

GBP 8.6651

20p ordinary

CFD

Increasing short

10,150

GBP 8.6653

20p ordinary

CFD

Increasing short

6,116

GBP 8.6654

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

Date of disclosure:

31 March 2021

Contact name:

Jana Blumenstein

Telephone number:

+44 20 7743 3650

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETDKDBQKBKDBNN
Date   Source Headline
20th Feb 20207:00 amRNSAUDITED RESULTS FOR THE YEAR ENDED 31/12/2019
4th Feb 20204:45 pmRNSNotice of Results
30th Jan 20207:00 amRNSGROUP PRODUCTION REPORT FOR THE FOURTH QUARTER
28th Jan 202011:43 amRNSREFINANCING OF PRE-EXPORT FINANCE DEBT FACILITY
31st Dec 201911:00 amRNSTotal Voting Rights
15th Nov 20193:48 pmRNSNEW $100 MILLION CREDIT FACILITY
31st Oct 20192:00 pmRNSTotal Voting Rights
29th Oct 20194:13 pmRNSDirector/PDMR Shareholding
24th Oct 20197:00 amRNSGROUP PRODUCTION REPORT
15th Oct 20192:00 pmRNSDirector Declaration
4th Oct 201911:00 amRNSDirector/PDMR Shareholding
10th Sep 20192:35 pmRNSHolding(s) in Company
2nd Sep 20192:00 pmRNSDirector Declaration
30th Aug 20193:00 pmRNSTotal Voting Rights
22nd Aug 20194:15 pmRNSDirector/PDMR Shareholding
16th Aug 20192:00 pmRNSDirector/PDMR Shareholding
15th Aug 20197:00 amRNSHalf-Yearly Report
1st Aug 201911:00 amRNSNotice of Results
31st Jul 201912:00 pmRNSTotal Voting Rights
30th Jul 20192:00 pmRNSHolding(s) in Company
25th Jul 20197:00 amRNSPRODUCTION REPORT FOR SECOND QUARTER
12th Jul 201910:00 amRNSHolding(s) in Company
11th Jul 20194:00 pmRNSHolding(s) in Company
4th Jul 20193:00 pmRNSHolding(s) in Company
3rd Jul 20195:06 pmRNSCompletion of Koksay Project Investment By NFC
28th Jun 20192:00 pmRNSTotal Voting Rights
27th Jun 20192:00 pmRNSReport on Payments to Govts
14th Jun 20193:55 pmRNSNEW $600 MILLION DEBT FACILITY
31st May 20192:00 pmRNSTotal Voting Rights
16th May 20194:29 pmRNSHolding(s) in Company
14th May 20192:00 pmRNSHolding(s) in Company
7th May 20192:30 pmRNSHolding(s) in Company
3rd May 201912:09 pmRNSTotal Voting Rights
2nd May 20194:27 pmRNSResult of AGM
29th Apr 20194:06 pmRNSHolding(s) in Company
25th Apr 20197:00 amRNSPRODUCTION REPORT FOR FIRST QUARTER ENDED 31/03/19
1st Apr 20192:00 pmRNSDirector/PDMR Shareholding
29th Mar 20194:00 pmRNSTotal Voting Rights
26th Mar 201910:00 amRNSHolding(s) in Company
20th Mar 201912:15 pmRNSPosting of Annual Report and Notice of AGM
4th Mar 201911:00 amRNSDirector/PDMR Shareholding
28th Feb 20192:00 pmRNSTotal Voting Rights
21st Feb 20197:00 amRNSAUDITED RESULTS FOR THE YEAR ENDED 31/12/18
6th Feb 20194:00 pmRNSNotice of Results
25th Jan 20191:30 pmRNSHolding(s) in Company
25th Jan 201911:00 amRNSHolding(s) in Company
24th Jan 20194:45 pmRNSHolding(s) in Company
24th Jan 20194:45 pmRNSHolding(s) in Company
24th Jan 20192:00 pmRNSHolding(s) in Company
24th Jan 20197:00 amRNSGROUP PRODUCTION REPORT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.